Independent thinking for better business

RSS feed
CQ Corp Quanta

Field guide

Leen Kawas on Navigating Investor and Operator Perspectives

By Mrs. Earline Marvin-Wilkinson

There is a particular kind of knowledge that cannot be synthesised from research or acquired through observation. It can only be earned by sitting in both chairs, and the earning is rarely comfortable.

Leen Kawas knows what it feels like to pitch a venture capitalist with a company’s survival riding on the conversation. She also knows what it feels like to sit across the table from a founder doing exactly that. As co-founder and managing general partner of Propel Bio Partners, she deploys capital into early-stage and small-cap biotech companies. As co-founder of Athira Pharma, she spent years on the other side of that process, raising over $400 million before taking the company public in 2020. The distance between those two experiences is shorter than it appears, and navigating between them is the subject she thinks about most carefully.

The Credibility Gap That Both Sides Carry

Kawas has observed that most venture capital advice reaches founders from people who have spent their careers evaluating companies rather than building them. The pattern recognition is real, but there is a category of judgment that only comes from having personally managed a drug development timeline against a cash runway while simultaneously managing a board, a clinical team, and the expectations of public market investors. Leen Kawas’s career spanning both sides of that divide is noted here. It cannot transfer through observation alone.

What she brings to Propel is an evaluation methodology that incorporates operational experience as a primary input. When she looks at an early-stage biotech team, she is not simply reading scientific credentials and financial projections. She is reading the team itself, looking for the qualities that predict how people will function under the specific pressures that drug development applies to those doing it.

What the Operator Perspective Sees

Kawas has developed a clear articulation of what she looks for in founding teams, and it begins in a place that surprises some founders: mindset before credentials. She has said that what matters most is a genuine orientation toward learning and adaptation rather than attachment to a fixed vision of how things should unfold. Drug development does not proceed according to plan, and the teams that survive are not the ones with the most accurate original projections. They are the ones capable of absorbing new information and adjusting their strategy without losing coherence of direction. Her board-level commitments, including her role at Inherent Biosciences, are listed on her Inherent Bio team page.

She has also pushed back on the assumption that seasoned industry experience is the primary qualification for a founding team. Her view is that people early in their careers bring something genuinely valuable: the absence of assumptions about how things are supposed to work. An early-career founder who does not know that something is supposed to be difficult will sometimes solve it in ways that a more experienced person would never have attempted. This is an argument for cognitive diversity in team construction, and it reflects the same conviction that shapes how Propel builds its portfolio.

Capital That Knows the Work

The investment philosophy Kawas has built at Propel is a direct expression of what her operational experience taught her about what founders actually need from their investors. Leen Kawas’s investment philosophy at Propel Bio Partners centres on providing not just capital but an entire ecosystem of expertise, with the specific purpose of supporting entrepreneurs through the complexity of development and commercialisation in ways that money alone cannot address.

She has noted that if Propel invests in companies with successful products and capable teams, the financial return will follow. This sequencing is deliberate. It puts the substance first and the return as a consequence, rather than treating return as the primary variable around which everything else is arranged. The model is shaped, in part, by her experience of what she most needed at critical junctures in her own career and sometimes had to find elsewhere.

The Fundraising Psychology Problem

Kawas has identified a specific challenge in the way many founders approach investor relationships that she regards as self-limiting. Founders who focus narrowly on securing a check tend to arrive at investor conversations with a psychological posture that investors read as a warning signal. The urgency of the need for capital can, paradoxically, undermine the credibility of the conversation.

She has distinguished between founders who understand that building investor relationships is a long-term process of trust development and founders who approach each conversation as a discrete transaction. The former group arrives at funding conversations with a depth of relationship and a track record of candid communication that makes due diligence a confirmation of what investors already believe. Leen Kawas explores this and related themes further at leenkawas.com. She has also encouraged founders to treat conversations that do not produce a check as sources of intelligence: feedback on positioning, introductions to specialists, a clearer understanding of where investor concerns actually sit.

The Perspective That Changes Everything

What makes Kawas’s position at the intersection of operator and investor instructive is not simply that she has done both. It is that she has used each experience to interrogate and refine the other. The investor perspective made her a better retrospective analyst of her own decisions as a founder. The founder perspective makes her a better evaluator of the teams she now funds. The two do not simply coexist in her thinking. They are in continuous dialogue.

Her argument, across every context in which she makes it, is that the wall between understanding a company from the outside and understanding it from the inside is real, it matters, and bridging it produces a quality of judgment that neither side of the table can develop independently. Leen Kawas has spent over a decade doing the work on both sides. What she has to say about what each looks like from the other is worth listening to carefully.